Target trial emulation to evaluate the effect of immune-related adverse events on outcomes in metastatic urothelial cancer.
Pichler R, Fritz J, Maier S, Hassler MR, Krauter J, D Andrea D, Laukhtina E, Gust K, Mori K, Tully KH, Niedersuess-Beke D, Korber L, Spiegelberg JA, Bauernhofer T, Subiela JD, Mayr R, Kronbichler A, Moschini M, Teoh J, Pradere B, Shariat SF, Ulmer H, Mertens LS; European Association of Urology–Young Academic Urologists (EAU-YAU): Urothelial Carcinoma Working Group.
Pichler R, et al. Among authors: moschini m.
Cancer Immunol Immunother. 2024 Dec 21;74(1):30. doi: 10.1007/s00262-024-03871-7.
Cancer Immunol Immunother. 2024.
PMID: 39708183
Free PMC article.